Advertisement
Advertisement
ELUT
Elutia Inc. Class A Common Stock
1.01
USDSponsored
+0.01
+1.12%
May 08, 16:00 UTC -4
Closed
After-Market
1.03
+0.02
+1.88%
ELUT Earnings Reports
Positive Surprise Ratio
ELUT beat 8 of 22 last estimates.
36%
Next Report
In 4 Days
Date of Next Report
May 14, 2026
Estimate for Q1 26 (Revenue/ EPS)
$3.06M
/-$0.15
Implied change from Q4 25 (Revenue/ EPS)
-6.45%
/-110.14%
Implied change from Q1 25 (Revenue/ EPS)
-49.25%
/+50.00%
Elutia Inc. Class A Common Stock earnings per share and revenue
On Mar 11, 2026, ELUT reported earnings of 1.48 USD per share (EPS) for Q4 25, beating the estimate of -0.14 USD, resulting in a 1136.41% surprise. Revenue reached 3.27 million, compared to an expected 3.37 million, with a -2.82% difference. The market reacted with a +27.19% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 3.06 million USD, implying an decrease of -110.14% EPS, and decrease of -6.45% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Werewolf Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+3.68%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
FAQ
What were Elutia Inc. Class A Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Elutia Inc. Class A Common Stock reported EPS of $1.48, beating estimates by 1136.41%, and revenue of $3.27M, -2.82% below expectations.
How did the market react to Elutia Inc. Class A Common Stock's Q4 2025 earnings?
The stock price moved up 27.19%, changed from $0.69 before the earnings release to $0.88 the day after.
When is Elutia Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for May 14, 2026.
What are the forecasts for Elutia Inc. Class A Common Stock's next earnings report?
Based on 4
analysts, Elutia Inc. Class A Common Stock is expected to report EPS of -$0.15 and revenue of $3.06M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement